MIMs Technology used in the project of Dr. Mark Basik against Breast Cancer.
Last June 1st, they announced three great projects financed by the Breast Cancer Research Society of Canada and CQDM.
Among the projects, there is the first clinical trial lead by Professor Mark Basik. They will be using the technology of MIMs in order to identify the subgroup of patients with an aggressive type of cancer and who will benefit from a second chemotherapy treatment.
We are very proud and happy to participate in this amazing project that will greatly improve the quality of life of millions of patients.